Humanized antibodies against CD269 (BCMA)

US11820829B2 · kind B2 · utility

Assignee

• Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft · DE

Inventors

• Felix Oden · Berlin, DE
• Stephen Marino · Berlin, DE
• Oliver Daumke · Berlin, DE

Key dates

• Filing date: Oct 23, 2020
• Grant date: Nov 21, 2023
• Expiry date: Jun 3, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N15/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A nucleic acid molecule encoding an antibody or antibody fragment, wherein the antibody or antibody fragment binds an epitope of the extracellular domain of CD269 (BCMA), a host cell comprising the nucleic acid molecule and a composition comprising the host cell.